scholarly journals Interracial differences in prostate cancer progression among patients from the United States, China and Japan

2013 ◽  
Vol 15 (6) ◽  
pp. 705-707 ◽  
Author(s):  
Haiyen E Zhau ◽  
Qinlong Li ◽  
Leland WK Chung
Keyword(s):  
Prostate Cancer ◽  
United States ◽  
Cancer Progression ◽  
The United States ◽  
Prostate Cancer Progression ◽  
China And Japan

Diet After Diagnosis and the Risk of Prostate Cancer Progression, Recurrence, and Death (United States)

2006 ◽  
Vol 17 (2) ◽  
pp. 199-208 ◽  
Author(s):  
June M. Chan ◽  
Crystal N. Holick ◽  
Michael F. Leitzmann ◽  
Eric B. Rimm ◽  
Walter C. Willett ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
United States ◽  
Cancer Progression ◽  
Prostate Cancer Progression

Interracial Comparative Study of Prostate Cancer in the United States, China, and Japan

1999 ◽  
Vol 161 (1) ◽  
pp. 352-352
Author(s):  
H.E. Zhau ◽  
L.-S. Zhao ◽  
B.-Q. Chen ◽  
M. Kojima
Keyword(s):  
Prostate Cancer ◽  
United States ◽  
Comparative Study ◽  
The United States ◽  
China And Japan

Signal transduction in prostate cancer progression

2005 ◽  
Vol 108 (4) ◽  
pp. 293-308 ◽  
Author(s):  
Daniel GIOELI
Keyword(s):  
Prostate Cancer ◽  
Cancer Progression ◽  
Late Stage ◽  
The United States ◽  
High Rate ◽  
Prostate Cancer Progression ◽  
Cancer Cell Growth ◽  
Androgen Independence ◽  
Growth Factor Signalling ◽  
Androgen Independent

Prostate cancer is the most frequently diagnosed cancer among men and the second leading cause of male cancer deaths in the United States. When prostate cancer initially presents in the clinic, the tumour is dependent on androgen for growth and, therefore, responsive to the surgical or pharmacological ablation of circulating androgens. However, there is a high rate of treatment failure because the disease often recurs as androgen-independent metastases. Surprisingly, this late-stage androgen-independent prostate cancer almost always retains expression of the AR (androgen receptor), despite the near absence of circulating androgens. Although late-stage prostate cancer is androgen-independent, the AR still seems to play a role in cancer cell growth at this stage of disease. Therefore a key to understanding hormone-independent prostate cancer is to determine the mechanism(s) by which the AR can function even in the absence of physiological levels of circulating androgen. This review will focus on the role of growth factor signalling in prostate cancer progression to androgen independence and thus outline potential molecular areas of intervention to treat prostate cancer progression.

463: Telomerase Inhibition Prevents Androgen Independent Osseous Prostate Cancer Progression

2005 ◽  
Vol 173 (4S) ◽  
pp. 126-127
Author(s):  
Yingming Li ◽  
Melissa Thompson ◽  
Zhu Chen ◽  
Bahaa S. Malaeb ◽  
David Corey ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Progression ◽  
Prostate Cancer Progression ◽  
Telomerase Inhibition ◽  
Androgen Independent

479: Prostate-Specific Membrane Antigen (PSMA) Expression as a Predictor of Prostate Cancer Progression

2006 ◽  
Vol 175 (4S) ◽  
pp. 155-156
Author(s):  
Matthias D. Hofer ◽  
Sven Perner ◽  
Haojie Li ◽  
Rainer Kuefer ◽  
Richard E. Hautmann ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Progression ◽  
Prostate Specific Membrane Antigen ◽  
Prostate Cancer Progression ◽  
Specific Membrane ◽  
Psma Expression
Sign in / Sign up

Export Citation Format

Share Document